May Han
Private Equity Investor at Cure Ventures Management LP
May Han active positions
| Companies | Position | Start | End |
|---|---|---|---|
Cure Ventures Management LP
 Cure Ventures Management LP Investment ManagersFinance Cure Ventures Management LP (Cure Ventures) is a venture capital firm founded in 2021 by David R Fallace, Richard J Lim and Lou A Tartaglia. The firm is headquartered in Boston, Massachusetts. | Private Equity Investor | 2021-08-31 | - |
Career history of May Han
Former positions of May Han
| Companies | Position | Start | End |
|---|---|---|---|
| NOVARTIS AG | Director/Board Member | 2013-09-30 | 2021-09-29 |
| AVEO PHARMACEUTICALS, INC. | Director/Board Member | 2003-09-30 | 2012-06-29 |
Training of May Han
| Peking University | Undergraduate Degree |
| Yale University | Doctorate Degree |
Statistics
International
| United States | 4 |
| Switzerland | 2 |
| China | 2 |
Operational
| Director/Board Member | 2 |
| Private Equity Investor | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Consumer Services | 3 |
| Health Technology | 3 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| NOVARTIS AG | Health Technology |
| Private companies | 2 |
|---|---|
Cure Ventures Management LP
Cure Ventures Management LP Investment ManagersFinance Cure Ventures Management LP (Cure Ventures) is a venture capital firm founded in 2021 by David R Fallace, Richard J Lim and Lou A Tartaglia. The firm is headquartered in Boston, Massachusetts. | Finance |
AVEO Pharmaceuticals, Inc.
 AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- May Han
- Experience
